Literature DB >> 19856414

MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function.

Jesus K Yamamoto-Furusho1, Nicolas Barnich, Tadakazu Hisamatsu, Daniel K Podolsky.   

Abstract

BACKGROUND: Human neutrophil peptide 1 (HNP-1) is a defensin with antibacterial activity secreted by various cells as a component of the innate immune host defense. NOD2 is a cytoplasmic protein that recognizes bacterial derived muramyl dipeptide, and is involved in bacterial clearance. The aim of the present study was to investigate the relationship between antibacterial activity of NOD2 and HNP-1 expression in epithelial cell lines.
METHODS: Gentamicin protection assay using Salmonella typhimurium was performed in Caco-2 cells. The mRNA level was determined by quantitative reverse-transcription polymerase chain reaction (RT-PCR) and defensin expression was assessed by Western blot and enzyme-linked immunosorbent assay (ELISA). Nuclear factor-kappaB activation was assessed using pIV luciferase and Renilla plasmids. A NOD2 mutant was generated by site-directed mutagenesis.
RESULTS: Among the defensins tested, only HNP-1 expression is induced in colonic epithelial model HCT116 cells after MDP-LD stimulation. HNP-1 secretion is significantly increased after MDP-LD stimulation in the cell supernatant of intestinal epithelial cells expressing endogenous NOD2, but not in cells that lack endogenous NOD2 expression. HNP-1 is required for NOD2-dependent NF-kappaB activation after MDP-LD stimulation since hnp-1 siRNA transfection abrogated the response to MDP-LD stimulation. The antibacterial function of NOD2 against S. typhimurium was impaired when expression of HNP-1 was blocked by siRNA.
CONCLUSIONS: HNP-1 secretion depends on NOD2 stimulation by MDP-LD and contributes to antibacterial activity in intestinal epithelial cells expressing endogenous NOD2, but not NOD2 3020insC mutant associated with increased susceptibility to Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19856414      PMCID: PMC2895931          DOI: 10.1002/ibd.21144

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  41 in total

Review 1.  Defensins and innate host defence of the gastrointestinal tract.

Authors:  C L Bevins; E Martin-Porter; T Ganz
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 2.  Paneth cell defensins and innate immunity of the small bowel.

Authors:  A J Ouellette; C L Bevins
Journal:  Inflamm Bowel Dis       Date:  2001-02       Impact factor: 5.325

Review 3.  Epithelial antimicrobial peptides: innate local host response elements.

Authors:  J M Schröder
Journal:  Cell Mol Life Sci       Date:  1999-10-01       Impact factor: 9.261

4.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

5.  The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.

Authors:  B Agerberth; J Charo; J Werr; B Olsson; F Idali; L Lindbom; R Kiessling; H Jörnvall; H Wigzell; G H Gudmundsson
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 6.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa.

Authors:  R N Cunliffe; M Kamal; F R A J Rose; P D James; Y R Mahida
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 8.  Cationic antimicrobial peptides and their multifunctional role in the immune system.

Authors:  M G Scott; R E Hancock
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

9.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

View more
  14 in total

1.  A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.

Authors:  Jill M Marinis; Craig R Homer; Christine McDonald; Derek W Abbott
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 2.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

3.  Neisseria gonorrhoeae Lytic Transglycosylases LtgA and LtgD Reduce Host Innate Immune Signaling through TLR2 and NOD2.

Authors:  Kayla J Knilans; Kathleen T Hackett; James E Anderson; Chengyu Weng; Joseph P Dillard; Joseph A Duncan
Journal:  ACS Infect Dis       Date:  2017-06-21       Impact factor: 5.084

4.  IκB kinase α phosphorylation of TRAF4 downregulates innate immune signaling.

Authors:  Jill M Marinis; Jessica E Hutti; Craig R Homer; Brian A Cobb; Lewis C Cantley; Christine McDonald; Derek W Abbott
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

5.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 6.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

Review 7.  Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.

Authors:  Avijit Ray; Bonnie N Dittel
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

8.  Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.

Authors:  Candice A Johnson; Girish Rachakonda; Yuliya Y Kleshchenko; Pius N Nde; M Nia Madison; Siddharth Pratap; Tatiana C Cardenas; Chase Taylor; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

Review 9.  Debug Your Bugs - How NLRs Shape Intestinal Host-Microbe Interactions.

Authors:  Simone Lipinski; Philip Rosenstiel
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

Review 10.  Interactions between Nod-Like Receptors and Intestinal Bacteria.

Authors:  Marcel R de Zoete; Richard A Flavell
Journal:  Front Immunol       Date:  2013-12-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.